LP429468-4CariprazineActive

Description

LP429468-4 Cariprazine
Cariprazine is one of the newest dopamine-serotonin partial agonists, also known as 'atypical' second generation antipsychotics. Originally approved for acute and maintenance treatment of schizophrenia as well as for acute mania and mixed mania/depression, cariprazine has now been approved for bipolar I depression. [PMID:32110377] Source: LOINC

Basic Part Properties

Name: Cariprazine
Type: Component
Created On: 2021-09-03
Construct for LOINC Short Name: Cariprazine

Related Codes

Code System	Code	Code Text	Code Version
https://www.ebi.ac.uk/chebi	CHEBI:90933	cariprazine	ChEBI Release 203
http://pubchem.ncbi.nlm.nih.gov	11154555	Cariprazine

LOINC FHIR^® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP429468-4

Language Variants Get Info

zh-CNChinese (China): 卡比米嗪
Synonyms: CAS 839712-12-8;卡利拉嗪;Vraylar;新型候选抗精神病药物;试验性非典型抗精神病用药，用于精神分裂症患者和双相Ⅰ型障碍相关的躁狂或混合发作患者
nl-NLDutch (Netherlands): cariprazine
it-ITItalian (Italy): Cariprazina
es-ESSpanish (Spain): Cariprazina

LOINC Copyright

Copyright © 2022 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2022, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.